Spyre Therapeutics
Justin LaFountaine, Ph.D. currently holds the position of Senior Vice President of Corporate Development at Spyre Therapeutics. With a background in pharmaceutical science and nanotechnology, Justin has held various leadership roles in companies such as Foresite Labs, BridgeBio, and L.E.K. Consulting. Justin's experience spans from research scientist at AbbVie to principal at Texas Venture Labs, showcasing his expertise in corporate development and business strategy.
Spyre Therapeutics
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.